EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Recent progress on formulations of hirudin

Zheng Bao, Xingyu Qi, Suling Zhu, Mao Zhang, Xinyue Liu, Peidong Chen, Li Zhang, Ting Geng, Fang-Fang Cheng

Pharmaceutical Science Advances · 2025-12 · 3 · 100078

DOI: 10.1016/j.pscia.2025.100078 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutical Science Advances, 2025-12. Verfasst von Zheng Bao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Centre of Chin…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National College Students Innovation and Entrepreneurship Training Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hirudin is an effective active ingredient derived from the salivary glands of leech. It is a small peptide molecule consisting of 65-66 amino acids and demonstrates a strong inhibitory effect on thrombin, providing beneficial anticoagulant and antithrombotic properties. However, as a biopharmaceutical peptide, it has some drawbacks such as easy degradation, short half-life, low bioavailability, and high risk of hemorrhage in clinical use. To overcome these challenges, various formulations were developed. In this work, a comprehensive review of research progress was provided in both traditional and novel hirudin formulations, spanning from lyophilized powders to biotechnology-based pharmaceuticals, covering various dosage forms to offer comprehensive references for field research. Firstly the advantages and limitations of conventional preparations were assessed such as freeze-dried powders, capsules, and injections. Then a detailed exploration of frontier strategies including nanotechnology-based delivery systems, transdermal formulations, and biotechnology-driven prodrug designs were conducted. This article aims to comprehensively analyze cutting-edge advancements in hirudin preparation research, providing updated information for relevant researchers by integrating traditional dosage optimization with breakthrough emerging technologies.

Schlagwörter

Stichwörter der Autor:innen

Anticoagulant activityDermal delivery formulationsHirudin formulationsMolecular design and structural modificationsRelease-controlled formulations

Autor:innen und Institutionen

  • Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Centre of Chinese Medicinal Resources Industrialization and Formulae Innovative Medi…
  • Nanjing University of Chinese Medicine Hanlin College, Taizhou, 225300, China.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National College Students Innovation and Entrepreneurship Training Program
  • National Natural Science Foundation of China

Zitieren

APA

Bao, Z., Qi, X., Zhu, S., Zhang, M., Liu, X., Chen, P., Zhang, L., Geng, T., & Cheng, F. F. (2025). Recent progress on formulations of hirudin. Pharmaceutical Science Advances, 3, 100078. https://doi.org/10.1016/j.pscia.2025.100078

Vancouver

Bao Z, Qi X, Zhu S, Zhang M, Liu X, Chen P, et al. Recent progress on formulations of hirudin. Pharmaceutical Science Advances. 2025;3:100078. doi:10.1016/j.pscia.2025.100078

BibTeX
@article{Bao2025,
  author = {Bao, Zheng and Qi, Xingyu and Zhu, Suling and Zhang, Mao and Liu, Xinyue and Chen, Peidong and Zhang, Li and Geng, Ting and Cheng, Fang-Fang},
  title = {Recent progress on formulations of hirudin},
  journal = {Pharmaceutical Science Advances},
  year = {2025},
  volume = {3},
  pages = {100078},
  doi = {10.1016/j.pscia.2025.100078}
}
Kostenlos starten →